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Here, we show that 3 days of mitochondrial uncoupling, induced by low concentrations of dinitrophenol (10 and 50 μM) in cultured human
HepG2 cells, triggers cellular metabolic adaptation towards oxidative metabolism. Chronic respiratory uncoupling of HepG2 cells induced an
increase in cellular oxygen consumption, oxidative capacity and cytochrome c oxidase activity. This was associated with an upregulation of
COXIV and ANT3 gene expression, two nuclear genes that encode mitochondrial proteins involved in oxidative phosphorylation. Glucose
consumption, lactate and pyruvate production and growth rate were unaffected, indicating that metabolic adaptation of HepG2 cells undergoing
chronic respiratory uncoupling allows continuous and efficient mitochondrial ATP production without the need to increase glycolytic activity. In
contrast, 3 days of dinitrophenol treatment did not change the oxidative capacity of human 143B.TK− cells, but it increased glucose consumption,
lactate and pyruvate production. Despite a large increase in glycolytic metabolism, the growth rate of 143B.TK− cells was significantly reduced by
dinitrophenol-induced mitochondrial uncoupling. We propose that chronic respiratory uncoupling may constitute an internal bioenergetic signal,
which would initiate a coordinated increase in nuclear respiratory gene expression, which ultimately drives mitochondrial metabolic adaptation
within cells.
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Mitochondrial oxidative phosphorylation produces most of
the energy in aerobic living system by coupling respiration
with the production of ATP. Respiration refers to the transfer
of electrons from substrates to oxygen, a process that creates
an electrochemical proton gradient across the inner mito-
chondrial membrane. The energy stored in this proton motiveAbbreviations:ANT, adenine nucleotide translocator; ARP, acidic ribosomal
phosphoprotein; COX, cytochrome c oxidase; DNP, 2,3-dinitrophenol; FBS,
fetal bovine serum; FCCP, carbonyl cyanide-p-trifluoromethoxyphenylhydra-
zone; NRF1, nuclear respiratory factor-1
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or by other proteins to drive ion and substrate transport. In
addition, the electrochemical proton gradient can also be
dissipated by proton leak reactions through either basal or
inducible proton conductance pathways [1]. Inner mitochon-
drial membrane proton leakage is an ubiquitous phenomenon
that diverts energy from ATP synthesis to thermogenesis,
thereby modulating the yield of ATP synthesis in the
mitochondria. It has been estimated that proton conductance
accounts for a high proportion of cellular metabolic rate [1–
3], causing up to 20% of standard metabolic rate in rats [2].
Accordingly, increased energy expenditure through increased
mitochondrial proton leak has been proved to represent a
treatment for obesity [4]. Mitochondrial proton conductance
may also represent a mechanism for the regulation of
mitochondrial reactive oxygen species production [5–8],
mediators of oxidative cell damage. In association with this
function, it has been suggested that mitochondrial proton leak
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the pathophysiology of diabetic complications [11]. Several
other studies also support the role for mitochondrial
uncoupling in the regulation of numerous other cellular
metabolic functions such as calcium signaling [12,13], lipid/
glucose metabolism [14–17] and beta cell glucose sensing
[18]. These findings therefore suggest that mitochondrial
proton leak might play a role in cellular metabolic
homeostasis, which includes, but is not restricted to, the
regulation of oxidative phosphorylation efficiency and heat
production.
Recently, some independent studies have provided data,
although scarce, suggesting that mitochondrial uncoupling
constitutes an internal metabolic signal triggering mitochon-
drial biogenesis that could culminate in an adaptation of
metabolic cell characteristics [19–21]. The aim of this work
was to further characterize the role of chronic mitochondrial
uncoupling in regulating cellular oxidative capacity and the
possible cross-talk with the nuclear transcription factor and
respiratory gene expression. We investigated the effect of 3
days of mitochondrial uncoupling induced by 2,4-dinitrophe-
nol (DNP) on substrate metabolism, respiratory capacity,
mitochondrial membrane potential and on the expression of
nuclear respiratory factor-1 (NRF1) and the nuclear genes that
encode mitochondrial proteins (COXIV, ANT2 and ANT3) in
human HepG2 and 143B.TK− cell lines. These two human
cell lines were chosen as they differ in their energetic
background, with HepG2 cells being more oxidative and
thereby being less dependent on glycolytic ATP as a source
of energy compared to 143B.TK− cells. We found that
uncoupling induced increased oxidative capacity in HepG2
cells, but not in 143B.TK− cells. This was associated with an
upregulation of HepG2 nuclear gene encoding COXIV and
ANT3 proteins. The intracellular signaling pathways poten-
tially involved in the reported causal link between mitochon-
drial uncoupling and adaptive changes in cellular respiratory
function are discussed.
2. Materials and methods
2.1. Cell lines and growth conditions
The HepG2 human hepatoma cell line was grown in RPMI 1640 medium,
supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine,
penicillin G (100 U/ml), streptomycin (2 mM) and amphoptericin B (0.25 μg/
ml). The osteosarcoma-derived cell line (143.TK−) was grown in DMEM F12
with 10% FBS, 2 mM L-glutamine and the same antibiotics as used for
HepG2 cells. Cells were seeded at a density of 15,000 cells per ml in a 20 ml
flask were grown at 37 °C in a humidified atmosphere (5% CO2–95% air) for
7 days in medium only (control) or in medium containing either 10 μM or 50
μM DNP. As DNP was made in ethanol solution, we used an experimental
control condition, in which cells were grown in medium supplemented with
ethanol (108 mM) only. Every 24 h (from J1 to J7), cells were collected by
trypsinization and resuspended in PBS containing 5% FBS. An aliquot of
each flask (control, ethanol, DNP 10 μM and DNP 50 μM) was colored using
erythrosine to test cell viability. Then, three independent countings were done
for each experimental culture condition. No differences in cell viability were
found between DNP-treated and control cells, reinforcing the fact that the two
concentrations of DNP used in the present work were not toxic towards
HepG2 and 143B.TK− cell lines [22].Doubling time was determined for each culture condition (control, ethanol,
DNP 10 μM and DNP 50 μM) using the exponential phase of the proliferation
curve [log(cell number)= f (day of culture)] as follows:
Doubling Time¼ ðT2 T1Þ=½lnðcell number atT2=cell number at T1Þ=lnð2Þ
where (T2−T1) is the duration of the exponential phase.
2.2. Measurement of oxygen consumption and FCCP titration of
respiration in intact cells
After 3 days of culture, control and DNP-treated HepG2 and 143B.TK− cells
were collected by trypsinization and washed once in RPMI (HepG2) or DMEM
(143B.TK−) containing 5% FBS and 2 mM L-glutamine. Two aliquots of each
experimental condition were removed for cell counting. Then, the remaining cell
suspensions were centrifuged (110 g for 5 min) and the pellet resuspended at a
final concentration of 10×106 cells per ml (HepG2) or 5×106 cells per ml
(143B.TK−) in 500 μl of the same medium supplemented with 2 mM L-
glutamine (without FBS, DNP or ethanol) and previously air-equilibrated at
37 °C. The supernatants were collected and stored at −80 °C until assayed.
The suspension was immediately transferred to the 1 ml chamber of a Clarke-
type oxygen electrode (Rank Brothers Ltd.) maintained at 37 °C using a
recirculating water bath and connected to a BD12E recorder model (Kipp and
Zonen). Basal endogenous coupled respiration rate of cells was determined by
measuring the linear rate of oxygen consumption, then oligomycin (12 μg/ml)
was added and the non-phosphorylating respiration rate recorded. After
recording the non-phosphorylating respiration rate, FCCP was added sequen-
tially at different concentrations (ranging from 100 to 1000 nM for HepG2 cells
and from 50 to 600 nM for 143B.TK−), and the uncoupled respiration rates
measured. This titration was done because the uncoupling activity of FCCP in
intact cells is biphasic, as shown in Fig. 1 for both hepatoma HepG2 and
osteosarcoma 143B.TK− cell lines. Therefore, we systematically achieved such
a titration in order to determine the optimal FCCP concentration that gives
maximal uncoupled respiration rate for each experimental condition.
Finally, myxothiazol (10 μM) was added to allow the measurement of non-
mitochondrial oxygen consumption rate in cells. Myxothiazol inhibited rates
were equally low in both untreated cell lines (6±2% of basal). In other words,
mitochondria accounted for 94±2% of basal respiration in both untreated
HepG2 and 143B.TK− cell lines, and its contribution to total cell respiration rate
was not significantly affected by DNP treatment (93±2% in 10 μMDNP-treated
and 92±2% in 50 μM DNP-treated cells compared with 90±3% of control
ethanol cells), excluding the possibility that non-mitochondrial oxygen
consumption rates differed between experimental conditions. The oxygen
solubility of the media was assumed to be 406 nmol O/ml. After recording
the respiration rates, 400 μl of cell suspensions were collected from the
chamber for total protein determination using the bicinchoninic acid procedure,
with bovine serum albumin used as standard (BC Assay kit®, Montluçon,
France).
Mitochondrial respiratory control ratio of cells was calculated as the ratio of
oxygen consumed by mitochondria in the presence of FCCP to that in the
presence of oligomycin, taking into account the myxothiazol rate [(VFCCP−
Vmyxo) / (Voligo−Vmyxo)]. To determine the respiratory activity of mitochondria in
intact cells, we expressed the basal endogenous respiration rate of mitochondria
as a fraction of their maximal respiration [(Vbasal−Vmyxo) / (VFCCP−Vmyxo)].
2.3. Measurement of mitochondrial membrane potential in intact
cells
Cells were grown as already described for the oxygen consumption
experiments. Three days after seeding, cells were collected by trypsinization and
washed in PBS with 10% FBS. The cells were then resuspended in PBS, FBS
5%, 50 mM KCl and incubated with 20 nM cationic fluorescent dye DiOC6(3)
in a 96-well plate (100,000 cells per well) for 30 min. In some wells, oligomycin
(5 μg/ml) or mClCCP (10 μM) was added before incubation, either to inhibit
ATP synthesis or to dissipate the proton gradient. After washing, the cells were
set in tubes containing propidium iodide (8 μg/ml) to check membrane integrity.
The fluorescent intensity was read using a flow cytometer (Becton-Dickinson).
Laser excitation of DiOC6(3) was at 484 nm and emission was read at 511 nm.
Fig. 1. Representative FCCP titration curves of non-phosphorylating oxygen consumption rate in HepG2 (×) and 143 B.TK− cells (+). After endogenous respiration
rate measurement and the addition of oligomycin (12 μg/ml), small amounts of FCCP were sequentially added in the polarographic chamber and a titration curve was
drawn. See Materials and methods for further details.
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was performed using Cell Quest software.
2.4. Mitochondrial enzyme activities
Cytochrome c oxidase and citrate synthase activities were measured using
standard spectrophotometric techniques [23]. The measurement of cytochrome c
oxidase activity was performed in cells following three freezing/thawing cycles,
by measuring decrease in absorbance resulting from the oxidation of reduced
cytochrome c at 550 nm. Citrate synthase activity was measured in the same
cells following the change in optical density of 5,5′-dithiobis(2-nitrobenzoic
acid) at 412 nm. The activity of complex I (NADH:Ubiquinone oxidoreductase)
was determined by monitoring the oxidation of NADH at 340 nm as described
by Kuznetsov and Gnaiger [24]. Briefly, a pellet of 5×106 cells was resuspended
in 250 μl PBS, froze in liquid nitrogen for 3 min. Then, frozen suspension was
thawed and centrifuged at 16,000×g for 30 s. The pellet was resuspended in PBS
at a final concentration of 1×106 cells per ml and sonicated on ice. An aliquot of
the resultant suspension was added to a K-phosphate buffer containing 0.3 mM
NADH, 0.1 mM Ubiquinone-1, 1 mM KCN and 2 mM NaN3, pH 7.4 and the
change in optical density of NADH was followed at 340 nm. After 120 s,
rotenone (1 μM) was added to measure rotenone-insensitive activity of the
preparation. Complex I activity was calculated as the total complex I activity
minus the rotenone-insensitive activity.
2.5. RNA analysis and quantitative real-time RT PCR
Total RNA was extracted from frozen pellets of cells cultured for
polarographic measurements (as described above) using the RNeasy Kit
(Quiagen). Reverse transcription of 1 μg total RNAwas performed in a total 20
μl volume. First, RNA was denaturated at 70 °C for 2 min with oligo dT (20
pmol). Then, 5× reaction buffer (50 mM Tris–HCl, pH 8.3, 75 mM KCl and 3
mMMgCl2), dNTPs mix (0.5 mM each), recombinant RNase inhibitor (1 U/μl)
and MMLV reverse transcriptase (200 units/mg RNA) was added.
Samples were finally incubated at 37 °C for 1 h and 5 min at 94 °C. 30 μl of
DEPC (treated with diethyl pyrocarbonate and autoclaved) water was added to
the reaction mixture to obtain a final 50 μl reaction volume (RT for PCR kit,
Clontech). cDNA previously synthesized were purified using the High Pure
PCR Product Purification Kit (Boerhinger, Mannheim, Germany). Amplifica-
tion products were then separated by gel (2.5% agarose) electrophoresis, stained
with ethidium bromide, visualized and quantified using an integrating camera
and analysis software (Molecular Analyst). Simultaneously, spectrophotomet-
rical quantification was done by measuring optical density of samples at 260 nm
(double strand DNA absorbancy wavelength) and 280 nm.The levels of transcripts for adenine nucleotide translocator 2 (ANT2),
ANT3, cytochrome c oxidase subunit IV (COXIV) and NRF1 were evaluated by
quantitative real time RT PCR, using LightCycler™ (Roche Molecular
Biochemicals, Mannheim, Germany) and LightCycler-RNA Amplification Kit
SYBR Green I (Roche). Standard PCR products were generated by amplifying
cDNA templates. Amplified fragments were then electrophoresed on agarose
gels to confirm their expected size. Transcript levels were expressed in relation
to that of acidic ribosomal phosphoprotein (ARP). PCR was performed using the
following primers : ARP : 5′-CGA CCT GGA AGT CCA ACTAC-3′ (forward)
and 5′-ATC TGC TGC ATC TGC TTG-3′ (reverse), ANT2 : 5′-GCT TGT GTA
TGA TGA AA-3′ (forward) and 5′-AGA AAA CTG GTC AGA TGA AA-3′
(reverse), ANT3 : 5′-TCG AGA AAT TCC AGT TGT CTT T-3′ (forward) and
5′- AGA ACA CGA CTT GGC TCC TAC A-3′ (reverse), COXIV : 5′-TTG
GCA AGC GAG CAA CC-3′ (forward) and 5′-TTC TCC TTC TCC TTC AAT
GC-3′ (reverse), NRF1 : 5′-ATC TAT CCG GAA GAG GCA AC-3′ (forward)
and 5′-GTG TTC TGC CAG AGC AGA CT-3′ (reverse).
2.6. Western blot analysis
Cells were grown, collected and counted as described above for the oxygen
consumption experiments. Pellets of 5×106 cells were stored at −80 °C until
used for western blot analysis. Frozen cells were lysated by an hypoosmotic
shock (resuspension of the pellet in 96 μl of DEPC water and 4 μl of
antiproteases). Protein concentration was determined by the Bio-Rad DC protein
Assay kit (BioRad, Hercules, CA, USA). Whole-cell lysates were boiled for 10
min at 100 °C. Twenty micrograms of total protein were separated on a 12.5%
SDS-polyacrylamide gel and electroblotted to a PVDF membrane (Amersham
Biosciences, UK). Membranes were saturated with 5% non fat milk dissolved in
TBS-Tween 0.1% (pH 7.4, NaCl 137 mM, KCl 2.7 mM, Tris 23 mM, Tween 20
0.1%) for 1 h at room temperature and incubated overnight at room temperature
with monoclonal mouse anti-COXIV (1:5000 Interchim, Montluçon, France)
and anti-VDAC (1:2500 Calbiochem, San Diego, USA). Membranes were then
washed three times in TBS-Tween 0.1% and incubated with horseradish
peroxidase-conjugated rabbit anti-mouse secondary antibody (1:10,000) for 1
h at room temperature. The immunoreactive proteins were visualized with
enhanced chemiluminescence (ECL Western Blotting Detection Reagents,
Amersham Biosciences, UK). Band intensities were quantified with Quantity
One software (Bio-Rad).
2.7. Analysis of glucose, lactate and pyruvate
Glucose and lactate concentrations in the culture media were determined by
spectrophotometry, using appropriate enzymatic kits (Boerhinger, Mannheim,
Fig. 2. Determination of cell growth. Cells were cultured for 7 days in control
conditions (open circles), or in the presence of ethanol (open triangles), or
treated with 10 μMDNP (gray triangles) or 50 μMDNP (black triangles). Every
day, one flask was counted three times for each culture condition. After 7 days, a
proliferation curve was drawn for HepG2 cells (A) and 143B TK− cells (B) and
the doubling time determined for each culture condition with the exponential
phase of the curve. Values are expressed as means±S.E.M. for n=2 independent
cell preparations.
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nheim, Germany). Pyruvate concentration was determined by measuring NADH
concentration decrease in presence of the lactate dehydrogenase enzyme using
spectrophotometry at a fixed wavelength of 340 nm. Glucose consumption and
lactate and pyruvate production were normalized to total cellular protein content,
as determined by the bicinchoninic acid assay kit (Uptima, Interchim,
Montluçon, France) with bovine serum albumin as standard.
2.8. Statistical analysis
Statistics were performed by a one-way analysis of variance (ANOVA). A
Scheffe's F test was subsequently used to test for differences between means.
Statistical significance was recognized at Pb0.05. Values are presented as
means±S.E.M.
3. Results
3.1. Determination of cell growth
Fig. 2A shows that the total number of cells harvested after 7
days of culture did not differ between each experimental growth
condition, suggesting that the proliferation rate of the HepG2
cell line remained unaffected by DNP treatment. This is
confirmed by the fact that the doubling time of DNP-treated
cells was similar to that of control cells (Fig. 2A, inset).
Nevertheless, cells incubated in the presence of 50 μMDNP split
up more slowly than control cells until 3 days after seeding,
however, they then recovered the same proliferation rate as the
control. Contrary to the HepG2 cell line, osteosarcoma-derived
human cell line (143B.TK−) proliferation was inhibited by DNP
treatment (Fig. 2B). The doubling time (Fig. 2B, inset) further
indicated that the more DNP-induced mitochondrial uncoupling,
the less 143B.TK− grew. Thus, unlike HepG2 cells, 143B.TK−
cells were not able to recover normal growth when incubated in
the presence of DNP. However, it is important to note that this
inhibitory effect of DNP on 143B.TK− cell proliferation was
reversible, and when uncoupled cells were seeded again, without
DNP, they grew at a rate similar to control cells (data not shown).
3.2. Glucose, lactate and pyruvate metabolism
Fig. 3 shows the effects of DNP treatment on glucose (panels
A and B), lactate (panels C and D) and pyruvate (panels E and F)
metabolism in both HepG2 (panels A, C and E) and 143B.TK−
cells (panels B, D and F). In HepG2 cell line, glucose
consumption (Fig. 3A), lactate (Fig. 3C) and pyruvate
production (Fig. 3E) were not significantly different between
control and uncoupled cells. In 143B TK− cells, contrary to the
HepG2 cell line, glucose consumption (R=0.79, Pb0.0001) and
lactate production (R=0.91, Pb0.0001) increased linearly with
the intensity of DNP-induced mitochondrial uncoupling, reach-
ing + 150%more in 50 μMDNP-treated 143B TK− cells than in
ethanol control cells, for both glucose consumption (Pb0.05,
Fig. 3B) and lactate production (Pb0.05, Fig. 3D). Lactate
production was also significantly and linearly related to glucose
consumption (R=0.96, Pb0.0001). The slope of the regression
line was 1.73, which means that 87% of the glucose consumed
was converted to lactate by glycolysis. This is calculated from
the ideal maximal value of 2 for the ratio of lactate production/glucose consumption, as in glycolysis 1 mol of glucose is
converted into 2 mol of lactate. Finally, pyruvate was consumed
by 143B.TK− cells, except for cells incubated with DNP 50 μM,
in which case pyruvate was produced in large amounts (Fig. 3F).
3.3. Mitochondrial membrane potential
The results shown in Fig. 4 are expressed as the percentage
of cell fluorescence in relation to the fluorescence of ethanol
control cells. In the two cells lines, mitochondrial membrane
potential significantly decreased after cells were grown with
DNP 10 μM for 3 days (−37% in HepG2 cell line and −23% in
143B TK− cell line). When cells were grown in the presence of
DNP 50 μM, a slight but not statistically significant 24%
depolarization was noted in HepG2 cells (P=0.08), whereas a
significant 11% increase in fluorescence signal was found in
Fig. 3. Measurement of glucose, lactate and pyruvate concentrations. Three days after seeding, supernatant of cells in culture was removed and glucose (panels A and
B), lactate (panels C and D) and pyruvate concentrations in media (panels E and F) were measured in both HepG2 (panels A, C and E) and 143B.TK− (panels B, D
and F) for ethanol control cells (white bars), and for cells cultured in the presence of 10 μM DNP (gray bars) or 50 μM DNP (black bars). Values are expressed as
means±S.E.M., n=5 per group. *Pb0.05 compared with control ethanol.
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the membrane potential within cells.
3.4. Respiratory parameters of intact cells
The rates of basal endogenous respiration and FCCP-induced
maximal respiration were approximately 50% and 75% higher in
untreated HepG2 cells than in untreated 143B.TK− cells (18.0±
1.6 and 35.6±3.5 natom O/min mg protein in HepG2 cells
versus 12.1±0.8 and 20.3±1.5 natom O/min mg protein in
143B.TK− cells, respectively). We also noted a higher
oligomycin-insensitive respiration rate in HepG2 (7.4±0.8
natom O/min mg protein, Pb0.05) than in 143B.TK− cells(5.3±0.5 natom O/min mg protein). However, respiratory
control ratio of HepG2 cells was not significantly different
from that of 143B.TK− , and in the basal state, mitochondria of
both cell lines operated at an average of 56±4% of maximal
respiration.
Table 1 shows the effects of DNP treatment on the rates of
basal endogenous respiration, oligomycin-insensitive respira-
tion and FCCP-induced maximal respiration in both HepG2 and
143B TK− cell lines. The rate of basal endogenous respiration
was significantly increased by approximately 30% in HepG2
cells treated with 50 μM DNP, an effect that was linearly
correlated with DNP concentrations (R=0.49, Pb0.05). Simi-
larly, FCCP-induced maximal respiration rates significantly
Fig. 4. Determination of mitochondrial membrane potential. Fluorescence of
ethanol control (empty bars), DNP 10 μM (gray bars) and DNP 50 μM (black
bars) cells pre-stained with DiOC6 (3) (20 nM) was determined by flow
cytometry. Residual fluorescence emitted in the presence of 10 μMmClCCPwas
subtracted from the fluorescence of cells incubated with DiOC6(3) (20 nM) and
oligomycin (5 μg/ml). Data is expressed as the percentage of fluorescence
intensity of ethanol control values and expressed as means±S.E.M. for n=3
independent cell preparations measured in duplicate. *Pb0.05 compared with
ethanol control.
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regardless of the concentration used, suggesting an overall
stimulation of HepG2 respiratory capacity in response to DNP-
induced mitochondrial uncoupling. Finally, DNP treatment did
not significantly increase either the oligomycin-insensitive
respiration rate of HepG2 cells nor any of the oxygen
consumption rates (basal, oligomycin or FCCP) in 143B.TK−
cells. In fact, FCCP-uncoupled respiration rate of 143B.TK−
cells was rather decreased following 3 days of culture with DNP
50 μM, at least when compared with cell grown in the presence
of 10 μM of DNP (−38%, Pb0.05). Consequently, the
respiratory control ratio of 143B.TK− cells was lower followingTable 1
Oxygen consumption rates of control ethanol and dinitropenol(DNP)-treated
cells
Cell lines Respiratory
parameters
Treatments
Ethanol DNP 10 μM DNP 50 μM
HepG2 Basal respiration 15.1±0.7 16.9±0.7 20.3±1.5 ⁎
+oligomycin 6.5±0.6 7.9±0.8 8.1±0.8
+FCCP 26.6±2.4 41.4±3.2 ⁎ 44.5±2.8 ⁎
RCR 4.9±0.4 5.3±1.0 5.9±0.5
143B.TK− Basal respiration 9.7±0.6 11.7±1.1 10.4±0.6
+oligomycin 5.0±0.4 6.5±0.7 6.2±0.3
+FCCP 21.7±1.7 30.0±3.6 17.4±1.7
RCR 5.5±0.9 5.1±0.7 3.2±0.4
Oxygen consumption rates were measured by polarography in the basal
condition, in the presence of oligomycin (+oligomycin), and after the addition of
FCCP (+FCCP). Respiration rates are expressed in natom of oxygen/min mg of
protein. Respiratory control ratios (RCR) were calculated as the ratio between
FCCP and oligomycin respiration rates, taking into account the myxothiazol rate.
For more details see Materials and methods. Values are expressed as
means±S.E.M. for n=5 independent cell preparations measured in duplicate.
⁎ Pb0.05 compared with ethanol control treatment.3 days of treatment with DNP 50 μM compared with either
ethanol control (−42%, Pb0.05) or 10 μM DNP treated cells
(−37%, P=0.07) (Table 1). In the basal state, we calculated that
mitochondria of 143B.TK− cells treated with 50 μM of DNP
operated at 60±6% of maximal respiration, a mitochondrial
respiratory activity slightly higher than that observed in ethanol
control (43±5%, P=0.07) or 10 μM DNP-treated cells (42±
6%, P=0.05). In contrast, DNP treatment did not significantly
alter respiratory control ratios of HepG2 cells (Table 1) nor the
proportion of maximal respiratory activity used by mitochondria
in intact cells (55±3% in ethanol control, 43±5% in 10 μM
DNP-treated, 45±4% in 50 μM DNP-treated cells).
It must be emphasized here that all the respiratory parameters
above were obtained in the absence of DNP, as cells were
harvested and washed with incubation medium without DNP
before experimental data were recorded. Hence, these results do
reflect a true metabolic adaptation of cells to DNP-induced
chronic mitochondrial uncoupling which is distinct from an
acute effect of DNP on cell respiration.
3.5. Mitochondrial enzyme activities
Table 2 reports the enzymatic activities of citrate synthase
and cytochrome c oxidase of HepG2 and 143B.TK− cells for
each experimental condition. Both mitochondrial enzyme
activities were not affected by experimental conditions
regardless of the cell line used, except for the enzymatic
activity of COX, which was significantly increased in HepG2
cells cultured with DNP 50 μM (Pb0.05). Table 2 also shows
that the enzymatic activity of complex I in HepG2 cells was
unaffected by the experimental conditions.
3.6. Expression of ANT3, COXIV, ANT2 and NRF1 genes
In HepG2 cells, 3 days of DNP treatment at 50 μM resulted in
a marked induction of ANT3 and COXIV expression, whereas
no significant change in both ANT2 and NRF1 mRNA levels
was detected. Interestingly, a significant increase in COXIV
mRNA levels was also detected in HepG2 cells after 3 days of
incubation with only 10 μM DNP. In 143B.TK− cells, none of
the expression of the four genes considered was significantly
affected following 3 days of DNP treatment, regardless of the
concentration used (Table 3).Table 2
Enzymatic measurements of cytochrome c oxidase, citrate synthase and
complex I activities
Cell lines Enzymes Treatments
Ethanol DNP 10 μM DNP 50 μM
HepG2 Cytochrome c oxidase 37.3±6.9 38.1±6.9 51.4±3.3 ⁎
Citrate synthase 305.4±14.4 294.2±17.8 319.2±32.2
Complex I 11.0±3.2 5.3±0.6 6.2±2.5
143B.TK− Cytochrome c oxidase 20.2±4.2 26.1±2.3 21.6±1.4
Citrate synthase 200.7±36.1 238.0±20.7 160.6±23.3
Cytochrome c oxidase, citrate synthase and complex I activities were determined
by enzymatic measurements. Results are expressed in nmol/min mg of protein.
⁎ Pb0.05 compared with ethanol control treatment.
Fig. 5. Expression of COXIV protein in HepG2 cells. HepG2 cells were cultured
in the presence of ethanol (white bar), 10 μM DNP (gray bar) or 50 μM DNP
(black bar) for 3 days. Cellular extracts were subjected to Western blotting using
VDAC and COXIV antibodies followed by densitometric quantitation of both
proteins. Values are expressed relative to ethanol control ratio as means±S.E.M.
for n=4 independent cell preparations measured in duplicate. *Pb0.05
compared with ethanol control.
Table 3
Quantification of COXIV, ANT3, ANT2 and NRF1 transcript levels
Cell lines Genes Treatments
Ethanol DNP 10 μM DNP 50 μM
HepG2 COXIV 0.09±0.02 0.19±0.02 ⁎ 0.18±0.04 ⁎
ANT3 0.27±0.04 0.28±0.03 0.57±0.06 ⁎
ANT2 0.29±0.01 0.29±0.05 0.32±0.01
NRF1 0.0031±0.0002 0.0050±0.0003 0.0020±0.0010
143B.TK− COXIV 0.08±0.02 0.10±0.01 0.08±0.0
ANT3 0.06±0.00 0.06±0.01 0.06±0.01
ANT2 0.63±0.02 0.63±0.05 0.65±0.02
NRF1 0.0062±0.0010 0.0053±0.0021 0.0041±0.0022
Total RNAwas extracted from cells following 3 days of culture in the presence
of ethanol, 10 μMDNP or 50 μMDNP. After reverse transcription, quantitative
RT PCRwas performed to determine the level of gene transcripts as described in
Materials and methods. Transcript levels were standardized with mRNA level of
ARP gene. Values are expressed as means±S.E.M. for n=3 independent cell
preparations measured in duplicate.
⁎ Pb0.05 compared with ethanol control.
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In HepG2 cells, the level of COXIV protein was significantly
increased in HepG2 cells cultured with DNP 50 μMbut not with
DNP 10 μM (Fig. 5). In contrast, DNP treatment (10 or 50 μM)
did not succeed in elevating COX protein level in 143B.TK−
cells (data not shown).
4. Discussion
The current work provides evidence that chronic mitochon-
drial uncoupling may constitute an internal bioenergetic signal
that ultimately drives metabolic adaptation of HepG2 cells
towards oxidative metabolism.
Indeed, we found that 3 days of DNP-induced mitochondrial
uncoupling in HepG2 induced an increase in the rates of basal
endogenous and FCCP-induced maximal oxygen consumption
(Table 1), and in cytochrome c oxidase activity (Table 2).
Additionally, the unchanged activity of citrate synthase suggests
that the increased respiratory activity of uncoupled HepG2 cells
did not result from an increased mitochondrial content, as the
change in the activity of this marker enzyme of the citric acid
cycle is widely accepted as being reliable and a valid indicator of
changes in mitochondrial volume density [25]. This increased
oxidative activity was associated with an upregulation of
COXIV and ANT3 gene expression (Table 3), two nuclear
genes that encode mitochondrial proteins involved in oxidative
phosphorylation processes. Interestingly, the COXIV transcript
level has been previously reported to increase in 3T3-L1
adipocytes after 10 h of incubation with 150 μM DNP or in
mature adipocytes from transgenic mice expressing UCP1 in
their white adipose tissue [20]. Furthermore, the increased
COXIV transcript levels reported herein was associated with an
increased COXIV protein expression (Fig. 5) showing that the
reported increase in cytochrome c oxidase activity involves
increased enzyme content. Villani et al. [26] have shown that
there is a low reserve of COX activity in vivo in the respiratory
chain of a variety of human cell types, including HepG2 cells.This suggests that the in vivo control of respiration by COX is
much tighter than has been assumed on the basis of experiments
carried out on isolated mitochondria. In this regard, the present
increase in the activity of COX has some significance for the
overall capacity of mitochondrial oxidative phosphorylation in
uncoupled HepG2 cells. Furthermore, the increase in the rate of
FCCP-induced maximal oxygen consumption strongly suggests
that other mitochondrial sites within the substrate oxidation
pathways (e.g., respiratory chain complexes other than complex
I (see Table 2), substrate dehydrogenases, substrate transport
systems) are involved in DNP-induced metabolic adaptation of
HepG2 cells. All these data clearly demonstrates that HepG2
cells develop their mitochondrial oxidative capacity in response
to chronicmitochondrial uncoupling, ametabolic adaptation that
allows HepG2 cells to produce energy efficiently to keep on
growing (Fig. 2A), without the need to increase glycolytic
activity (Fig. 3A and C).
As mentioned above, glucose consumption was not signif-
icantly changed in HepG2 cells following 3 days of DNP-
induced mitochondrial uncoupling. However, mitochondrial
membrane potential was depressed in uncoupled cells (Fig. 4), a
situation where mitochondria, and by extension cells, should
increase there substrate consumption. This relative discrepancy
results from our choice to focus the present study on the effects
of respiratory uncoupling upon glucose and glycolytic bypro-
ducts (lactate and pyruvate) rather than on oxidative substrate,
namely glutamine that was also present in the culture media (see
Materials and methods section). For this reason, the possibility
cannot be excluded that glutamine, for instance, was indeed
preferentially oxidized by uncoupled cells. This would be in line
with previous observations showing that overexpression of
uncoupling protein in cultured cells favours oxidative substrate
(e.g. fatty acid) versus glucose oxidation [14,15]. Although we
cannot substantiate this hypothesis, it should be noted that the
present study clearly shows that chronic respiratory uncoupling
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regulation of mitochondrial oxidative capacity.
Contrary to HepG2 cells, 3 days of DNP treatment did not
change the oxidative capacity of 143B.TK− cells, instead it
increased their glycolytic metabolism. Thus, in 143B.TK− cell
lines, DNP treatment significantly increased glucose consump-
tion (Fig. 3B) and lactate production (Fig. 3D) in a dose
dependent manner. The strong positive correlation between
glucose consumption and lactate production with a ratio lactate/
glucose of almost 2:1 (measured by the slope of the regression
line equation), indicating that most of the glucose uptake into
uncoupled 143B.TK− cells is reduced down the glycolytic
pathway to produce energy. Nevertheless, despite this stimula-
tion of glycolytic metabolism, the growth rate of 143B.TK−
cells was very sensitive to mitochondrial uncoupling, being
significantly reduced by DNP treatment (Fig. 2B). Interestingly,
treatment of 143B.TK− cells with 50 μM DNP induced a slight
but significant increase in the mitochondrial membrane
potential which corresponded with a large stimulation of
glycolysis and a drastic slow proliferation rate downwards.
These results would be consistent with the fact that glycolytic
ATP, the principal source of energy in 143B TK− cells, may
supply the energy for maintaining mitochondrial membrane
potential and cell proliferation [27]. In the presence of 50 μM
DNP, glycolysis may therefore not succeed in producing
enough ATP to allow 143B.TK− cells to grow efficiently
while maintaining their mitochondrial membrane potential.
Compared to HepG2 cell, our results show that the highFig. 6. Schematic diagram of the effect of chronic respiratory uncoupling on HepG2
(DNP) upregulates the expression of COXIVand ANT3 genes and COXIV protein lead
adaptation of uncoupled HepG2 cells results from mitochondrial cross-talk with t
pathway(s), followed by activation of specialized transcription factors initiates a co
uncoupling, at least two rapid events have been described that could form part of the in
lower cellular energy charge and the attendant increase in cytosolic AMP/ATP ratio [3
event is known to activate AMP-activated protein kinase [31,34,35], and the second ev
kinases, conventional protein kinase C) and phosphatases (e.g., calcineurine). These
coactivators toward an adjustment in mitochondrial metabolism within cells [36–38sensitivity to DNP-induced uncoupling in 143B.TK− cells may
be linked to their inability to develop mitochondrial energetic
pathway to synthesize ATP.
The dual genomic organization of the mitochondrial
oxidative phosphorylation complexes, which includes cyto-
chrome c oxidase, implies that any adaptive change in
mitochondrial characteristics must involve the coordinated
expression of genes originating from both nuclear and
mitochondrial genomes [28]. Therefore, the reported adaptive
increase in mitochondrial oxidative activity of HepG2 in
response to chronic respiratory uncoupling strongly suggests
that a signaling pathway must originate from mitochondria,
followed by the triggering of specialized transcription factors
that initiate a coordinated increase in nuclear respiratory gene
expressions (Fig. 6). Among the transcription factors, nuclear
receptors and coactivators that regulate the expression of
nuclear genes encoding mitochondrial proteins, NRF1 is the
only one for which expression had been studied in response to
respiratory uncoupling so far [19,20]. These studies reported
that respiratory uncoupling increased the expression of NRF1 in
HeLa cells 16 h after inducible expression of UCP1 [19] or in
3T3-L1 adipocytes incubated for 10 h with 150 μM DNP [20].
However, no significant change on NRF1 mRNA levels was
observed in mature adipocytes isolated from 7-month-old
transgenic mice expressing ectopic UCP1 in their white fat
[20]. As far as our study is concerned, the levels of NRF1
mRNAwere not significantly changed in HepG2 cells incubated
for 3 days with either 10 μM or 50 μMDNP, despite an adaptivecell metabolism. Three days of respiratory uncoupling induced by dinitrophenol
ing to increased mitochondrial oxidative activity in HepG2 cells. This metabolic
he expression of nuclear respiratory genes, implies that intracellular signaling
ordinated expression of nuclear respiratory genes. At the onset of respiratory
itial signaling process leading to activation of various transcription pathways: (1)
1,32] and (2) an increase in cytosolic calcium concentration [12,33]. The former
ent can activate a number of kinases (e.g. calcium/calmodulin-dependent protein
events would ultimately alter the expression of transcription factors and nuclear
].
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The relative discrepancy between these studies may simply
reveal the early molecular event that leads to mitochondrial
differentiation or proliferation in response to changes in cellular
bioenergetics. The hypothesis postulates that respiratory
uncoupling triggers the immediate expression of NRF1 (within
a few hours), followed by the up-regulation of NRF1-sensitive
genes, such as ä-aminolevulinate synthase [19], cytochrome c
and other nuclear genes required for respiratory chain expression
and function [29]. This would contribute to the cellular energy
metabolism adaptation and subsequent normalization of the
initial signaling event that had induced NRF1 expression.
Additionally, the increased COXIV transcript levels found in
uncoupled cells (present study, see also [20]), a gene that is not
sensitive to NRF1 [29,30], further suggests that other transcrip-
tion factors, in particular NRF2 in this case, are likely to be
involved in the stimulation of mitochondrial differentiation by
respiratory uncoupling. We are currently working on this
hypothesis in order to clarify whether the mitochondrial
respiratory adaptation reported herein could be related to the
early expression of NRF1 and other transcriptional activators
(NRF2, mtTFA) and coactivators (PGC1, PRC). Finally, the
present study provides evidence that modifications in mito-
chondrial bioenergetics influences the expression of nuclear
genes which would in turn regulate mitochondrial characteristics
and therefore cellular metabolism, at least in HepG2 (Fig. 6).
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